![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Heldin Carl-Henrik
Publisher: Springer Publishing Company
ISSN: 1557-1890
Source: Journal of Neuroimmune Pharmacology, Vol.9, Iss.2, 2014-03, pp. : 69-79
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Pathak Swati Roth Michael Verma Amit Steidl Ulrich
Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 12, 2013-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting PDGF pathway in pulmonary arterial hypertension
Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. :